The clinical relevance of the IgM isotype of antiphospholipid antibodies in the vascular antiphospholipid syndrome

Thrombosis Research

Volumn 136, Issue 5, 2015, Pages 883-886

  Del Ross, Teresa ^a   Ruffatti, Amelia ^a   Cuffaro, Serena ^a   Tonello, Marta ^a   Calligaro, Antonia ^a   Favaro, Maria ^a   Facchinetti, Myriam ^a   Hoxha, Ariela ^a   Punzi, Leonardo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Antiphosholipid antibody syndrome; Classification criteria; IgM isotype; Retinal thrombosis; Thrombosis

Indexed keywords

AUTOANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; IMMUNOGLOBULIN M ANTIBODY; PHOSPHOLIPID ANTIBODY; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; AUTOIMMUNE DISEASE; CHILD; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; RETINA DISEASE; RETINAL THROMBOSIS; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; VASCULAR ANTIPHOSPHOLIPID SYNDROME; VASCULAR DISEASE; VENOUS THROMBOEMBOLISM; IMMUNOLOGY; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; CHILD; FEMALE; HUMANS; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84948717817     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2015.08.019     Document Type: Article

References (29)

1. S. Miyakis, M.D. Lockshin, T. Atsumi, D.W. Branch, R.L. Brey, R. Cervera, and et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J. Thromb. Haemost. 4 2006 295 306
2. C. Neville, J. Rauch, J. Kassis, E.R. Chang, L. Joseph, M. Le Comte, and et al. Thromboembolic risk in patients with high titer anticardiolipin and multiple antiphospholid antibodies Thromb. Haemost. 90 2003 108 115
3. V. Pengo, A. Biasiolo, C. Pegoraro, U. Cucchini, F. Noventa, and S. Iliceto Antibody profiles for the diagnosis of antiphospholipid syndrome Thromb. Haemost. 93 2005 1147 1152
4. A. Ruffatti, M. Tonello, T. Del Ross, A. Cavazzana, C. Grava, F. Noventa, and et al. Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity Thromb. Haemost. 96 2006 337 341
5. M. Galli, G. Reber, P. De Moerloose, and P.G. De Groot Invitation to a debate on the serological criteria that define the antiphospholipid syndrome J. Thromb. Haemost. 6 2008 399 401
6. M. Galli, G. Borrelli, E.M. Jacobsen, R.M. Marfisi, G. Finazzi, R. Marchioli, and et al. Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study Blood 110 2007 1178 1183
7. M. Galli, D. Luciani, G. Bertolini, and T. Barbui Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature Blood 101 2003 1827 1832
8. M. Galli, D. Luciani, G. Bertolini, and T. Barbui Antiβ2-glycoprotein I, antiprothrombin antibodies and the lupus anticoagulants are stronger risk factors of thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome Blood 102 2003 2717 2723
9. M.C. Boffa, C. Boinot, S. De Carolis, P. Rovere-Querini, M.H. Aurousseau, F. Allegri, and et al. Laboratory criteria of the obstetrical antiphospholipid syndrome. Data from a multicentric prospective European women cohort Thromb. Haemost. 102 2009 25 28
10. A. Tincani, F. Allegri, G. Balestrieri, G. Reber, M. Sanmarco, P.L. Meroni, and et al. Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European forum on antiphospholipid antibodies Thromb. Res. 114 2004 553 558
11. G. Reber, A. Tincani, M. Sanmarco, P. de Moerloose, and M.C. Boffa Proposal for the measurement of anti-beta2-glycoprotein I antibodies. Standardization group of the European forum on antiphospholipid antibodies J. Thromb. Haemost. 2 2004 1860 1862
12. G. Lakos, E.J. Favaloro, E.N. Harris, P.L. Meroni, A. Tincani, R.C. Wong, and et al. International consensus guidelines on anticardiolipin and anti-β2-glycoprotein I testing Arthritis Rheum. 64 2012 1 10
13. S.S. Pierangeli, and E.N. Harris Clinical laboratory testing for the antiphospholipid syndrome Clin. Chim. Acta 357 2005 17 33
14. K. Ichikawa, M.A. Khamashta, T. Koike, E. Matsuura, and G.R. Hughes Beta 2-glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome Arthritis Rheum. 37 1994 1453 1461
15. W.A. Wilson, A.E. Gharavi, T. Koike, M.D. Lockshin, D.W. Branch, J.C. Piette, and et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop Arthritis Rheum. 42 1999 1309 1311
16. J.T. Brandt, D.A. Triplett, B. Alvin, and I. Scharrer Criteria for the diagnosis of lupus anticoagulant. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH Thromb. Haemost. 74 1995 1185 1190
17. V. Pengo, A. Tripodi, C. Reber, J.H. Rand, T.L. Ortel, M. Galli, and P.G. de Groot Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Update of the guidelines for lupus anticoagulant detection J. Thromb. Haemost. 7 2009 1737 1740
18. A. Martinez-Berriotxoa, G. Ruiz-Irastorza, M.V. Egurbide, M. Garmendia, J. Gabriel Erdozain, I. Villar, and et al. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus Lupus 16 2007 810 816
19. M.G. Tektonidou, K. Laskari, D.B. Panagiotakos, and H.M. Moutsopoulos Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies Arthritis Rheum. 61 2009 29 36
20. J. Calvo-Alen, S.M. Toloza, M. Fernandez, H.M. Bastian, B.J. Fessler, and J.M. Roseman LUMINA Study Group Systemic lupus erythematosus in a multiethnic US cohort (LUMINA).XXV.Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients Arthritis Rheum. 52 2005 2060 2068
21. D. Erkan Lupus and thrombosis J. Rheumatol. 33 2006 1715 1717
22. J. Swadzba, T. Iwaniec, A. Szczeklik, and J. Musial Revised classification criteria for antiphospholipid syndrome and the thrombotic risk in patients with autoimmune diseases J. Thromb. Haemost. 5 2007 1883 1889
23. Y.C. Yen, S.F. Weng, H.A. Chen, and Y.S. Lin Risk of retinal vein occlusion in patients with systemic lupus erythematosus: a population-based cohort study Br. J. Ophthalmol. 97 2013 1192 1196
24. K.J. Brandt, E.K.O. Kruithof, and P. de Moerloose Receptors involved in cell activation by antiphospholipid antibodies Thromb. Res. 132 2013 408 413
25. R. Cervera, J.C. Piette, J. Font, M.A. Khamashta, Y. Shoenfeld, M.T. Camps, S. Jacobsen, and et al. Euro-phospholipid project group. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients Arthritis Rheum. 46 2002 1019 1027
26. J.L. Vianna, M.A. Khamashta, J. Ordi-Ros, J. Font, R. Cervera, A. Lopez-Soto, and et al. Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients Am. J. Med. 96 1994 3 9
27. A. Ruffatti, T. Del Ross, M. Ciprian, M.T. Bertero, S. Sciascia, S. Scarpato, and et al. Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study Ann. Rheum. Dis. 70 2011 1083 1086
28. V. Pengo, A. Ruffatti, C. Legnani, P. Gresele, D. Barcellona, N. Erba, and et al. Clinical course of high-risk patients diagnosed with antiphospholipid syndrome J. Thromb. Haemost. 8 2010 237 242
29. M. Janssen, M. den Heijer, J. Cruysberg, H. Wolersheim, and S. Bredie Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors Thromb. Haemost. 93 2005 1021 1026